Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model

Molecular and Cellular Neuroscience

Volumn 77, Issue , 2016, Pages 65-75

  Rcom H'cheo Gauthier, Alexandre N ^a   Davis, Amelia ^a   Meedeniya, Adrian C B ^a   Pountney, Dean L ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Alpha synuclein; Calbindin D28k; Calcium; Dementia with Lewy Bodies; Neurodegeneration; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CALBINDIN 1; NEURONAL CALCIUM SENSOR; PROTEIN AGGREGATE; ROTENONE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CEREBELLUM; CINGULATE GYRUS; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MALE; MOTOR CORTEX; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TEMPORAL LOBE; VISUAL CORTEX; YOUNG ADULT; ANIMAL; C57BL MOUSE; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANIMALS; CALBINDIN 1; HUMANS; LEWY BODY DISEASE; MICE; MICE, INBRED C57BL; NEURONS; OXIDATIVE STRESS; PROTEIN AGGREGATES; ROTENONE;

EID: 84993953542     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2016.10.003     Document Type: Article

References (45)

1. Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V.M., Trojanowski, J.Q., Iwatsubo, T., Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:4 (1998), 879–884.
2. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000), 1301–1306.
3. Beyer, K., Ariza, A., Protein aggregation mechanisms in synucleinopathies: commonalities and differences. J. Neuropathol. Exp. Neurol. 66:11 (2007), 965–974.
4. Breydo, L., Wu, J.W., Uversky, V.N., Alpha-synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta 1822 (2012), 261–285.
5. Bu, J., Sathyendra, V., Nagykery, N., Geula, C., Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Exp. Neurol. 182 (2003), 220–231.
6. Castro Mdel, R., Suarez, E., Kraiselburd, E., Isidro, A., Paz, J., et al. Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp. Gerontol. 47 (2012), 29–37.
7. Chan, C.S., Guzman, J.N., Ilijic, E., Mercer, J.N., Rick, C., et al. ‘Rejuvenation’ protects neurons in mouse models of Parkinson's disease. Nature 447 (2007), 1081–1086.
8. Cookson, M.R., alpha-Synuclein and neuronal cell death. Mol. Neurodegener., 4, 2009, 9.
9. Dalfó, E., Ferrer, I., Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases. Neurobiol. Aging 29:3 (2008), 408–417.
10. Danzer, K.M., Krebs, S.K., Wolff, M., Birk, G., Hengerer, B., Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J. Neurochem. 111 (2009), 192–203.
11. Dryanovski, D.I., Guzman, J.N., Xie, Z., Galteri, D.J., Volpicelli-Daley, L.A., Lee, V.M., Miller, R.J., Schumacker, P.T., Surmeier, D.J., Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J. Neurosci. 33:24 (2013), 10154–10164.
12. Follett, J., Darlow, B., Wong, M.B., Goodwin, J., Pountney, D.L., Potassium depolarization and raised calcium induces alpha-synuclein aggregates. Neurotox. Res. 23 (2013), 378–392.
13. Gaspar, P., Ben Jelloun, N., Febvret, A., Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice. Neuroscience 61 (1994), 293–305.
14. German, D.C., Manaye, K.F., Sonsalla, P.K., Brooks, B.A., Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann. N. Y. Acad. Sci. 648 (1992), 42–62.
15. Goodwin, J., Nath, S., Engelborghs, Y., Pountney, D.L., Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation. Neurochem. Int. 62 (2013), 703–711.
16. Halhali, A., Figueras, A.G., Diaz, L., Avila, E., Barrera, D., et al. Effects of calcitriol on calbindins gene expression and lipid peroxidation in human placenta. J. Steroid Biochem. Mol. Biol. 121 (2010), 448–451.
17. Jellinger, K.A., Formation and development of Lewy pathology: a critical update. J. Neurol. 256:Suppl. 3 (2009), 270–279.
18. Jellinger, K.A., A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim. Biophys. Acta 1792 (2009), 730–740.
19. Jenner, P., Morris, H.R., Robbins, T.W., Goedert, M., Hardy, J., Ben-Shlomo, Y., Bolam, P., Burn, D., Hindle, J.V., Brooks, D., Parkinson's disease—the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J. Parkinsons Dis. 3:1 (2013), 1–11, 10.3233/JPD-130175.
20. Kim, B.G., Shin, D.H., Jeon, G.S., Seo, J.H., Kim, Y.W., et al. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat parkinsonian model. Brain Res. 855 (2000), 162–165.
21. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998), 106–108.
22. Kume, K., Kikukawa, M., Hanyu, H., Takata, Y., Umahara, T., Sakurai, H., Kanetaka, H., Ohyashiki, K., Ohyashiki, J.H., Iwamoto, T., Telomere length shortening in patients with dementia with Lewy bodies. Eur. J. Neurol. 19:6 (2012), 905–910.
23. Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honore, A., et al. G51D alpha-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 73 (2013), 459–471.
24. Lin, M.T., Cantuti-Castelvetri, I., Zheng, K., Jackson, K.E., Tan, Y.B., Arzberger, T., Lees, A.J., Betensky, R.A., Beal, M.F., Simon, D.K., Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann. Neurol. 71:6 (2012), 850–854.
25. Lowe, R., Pountney, D.L., Jensen, P.H., Gai, W.P., Voelcker, N.H., Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci. 13 (2004), 3245–3252.
26. Marques, O., Outeiro, T.F., Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis., 3, 2012, e350.
27. Nath, S., Goodwin, J., Engelborghs, Y., Pountney, D.L., Raised calcium promotes alpha-synuclein aggregate formation. Mol. Cell. Neurosci. 46 (2011), 516–526.
28. Nielsen, M.S., Vorum, H., Lindersson, E., Jensen, P.H., Ca2 + binding to alpha-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 276 (2001), 22680–22684.
29. Norazit, A., Meedeniya, A.C., Nguyen, M.N., Mackay-Sim, A., Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle. Brain Res. 1360 (2010), 119–129.
30. Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P.J., Pöyhönen, M., Paetau, A., A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol. Aging, 35(9), 2014, 2180, e1–5.
31. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997), 2045–2047.
32. Proukakis, C., Dudzik, C.G., Brier, T., MacKay, D.S., Cooper, J.M., Millhauser, G.L., Houlden, H., Schapira, A.H., A novel α-synuclein missense mutation in Parkinson disease. Neurology 80:11 (2013), 1062–1064.
33. Putcha, P., Danzer, K.M., Kranich, L.R., Scott, A., Silinski, M., et al. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J. Pharmacol. Exp. Ther. 332 (2010), 849–857.
34. Quilty, M.C., King, A.E., Gai, W.P., Pountney, D.L., West, A.K., et al. Alpha-synuclein is upregulated in neurons in response to chronic oxidative stress and is associated with neuroprotection. Exp. Neurol. 199 (2006), 249–256.
35. Radford, R., Rcom-H'cheo-Gauthier, A., Wong, M.B., Eaton, E.D., Quilty, M., Blizzard, C., Norazit, A., Meedeniya, A., Vickers, J.C., Gai, W.P., Guillemin, G.J., West, A.K., Dickson, T.C., Chung, R., Pountney, D.L., The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions. Mol. Cell. Neurosci. 65 (2015), 68–81.
36. Rcom-H'cheo-Gauthier, A., Goodwin, J., Pountney, D.L., Interactions between calcium and alpha-synuclein in neurodegeneration. Biomolecules, 4, 2014, 10.3390/biom40x000x.
37. Saito, Y., Miyasaka, T., Hatsuta, H., Takahashi-Niki, K., Hayashi, K., Mita, Y., Kusano-Arai, O., Iwanari, H., Ariga, H., Hamakubo, T., Yoshida, Y., Niki, E., Murayama, S., Ihara, Y., Noguchi, N., Immunostaining of oxidized DJ-1 in human and mouse brains. J. Neuropathol. Exp. Neurol. 73:7 (2014), 714–728.
38. Sanders, L.H., Greenamyre, J.T., Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic. Biol. Med. 62 (2013), 111–120.
39. Schapira, A.H., Olanow, C.W., Greenamyre, J.T., Bezard, E., Slowing of Neurodegeneration in Parkinson's Disease and Huntington's Disease: Future Therapeutic Perspectives. 2014 (Lancet).
40. Sims-Robinson, C., Hur, J., Hayes, J.M., Dauch, J.R., Keller, P.J., et al. The role of oxidative stress in nervous system aging. PLoS One, 8, 2013, e68011.
41. Tsuboi, K., Kimber, T.A., Shults, C.W., Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion. Brain Res. 866 (2000), 55–64.
42. Vila, M., Jackson-Lewis, V., Guegan, C., Wu, D.C., Teismann, P., et al. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14 (2001), 483–489.
43. Weetman, J., Wong, M.B., Sharry, S., Rcom-H'cheo-Gauthier, A., Gai, W.P., et al. Increased SUMO-1 expression in the unilateral rotenone-lesioned mouse model of Parkinson's disease. Neurosci. Lett. 544 (2013), 119–124.
44. Yamada, T., McGeer, P.L., Baimbridge, K.G., McGeer, E.G., Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526 (1990), 303–307.
45. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004), 164–173.